"[7B71749281AF]" . "Dasatinib - nov\u00E1 mo\u017Enost c\u00EDlen\u00E9 l\u00E9\u010Dby nemocn\u00FDch s CML rezistentn\u00ED na imatinib"@en . "Dasatinib - nov\u00E1 mo\u017Enost c\u00EDlen\u00E9 l\u00E9\u010Dby nemocn\u00FDch s CML rezistentn\u00ED na imatinib" . "L\u00E9\u010Div\u00FD p\u0159\u00EDpravek Sprycel vyr\u00E1b\u00ED firma Bristol-Myers Squibb a je od listopadu 2006 v Evropsk\u00E9 unii a t\u00EDm i v \u010Cesk\u00E9 republice registrov\u00E1n k l\u00E9\u010Db\u011B dosp\u011Bl\u00FDch s chronickou myeloidn\u00ED leuk\u00E9mi\u00ED (CML) s rezistenc\u00ED \u010Di intoleranc\u00ED na p\u0159edchoz\u00ED l\u00E9\u010Dbu v\u010Detn\u011B l\u00E9\u010Dby imatinibem a s Ph-pozitivn\u00ED akutn\u00ED lymfoblastickou leuk\u00E9mi\u00ED (Ph+ALL) rezistenc\u00ED \u010Di intoleranc\u00ED na p\u0159edchoz\u00ED l\u00E9\u010Dbu."@en . "L\u00E9\u010Div\u00FD p\u0159\u00EDpravek Sprycel vyr\u00E1b\u00ED firma Bristol-Myers Squibb a je od listopadu 2006 v Evropsk\u00E9 unii a t\u00EDm i v \u010Cesk\u00E9 republice registrov\u00E1n k l\u00E9\u010Db\u011B dosp\u011Bl\u00FDch s chronickou myeloidn\u00ED leuk\u00E9mi\u00ED (CML) s rezistenc\u00ED \u010Di intoleranc\u00ED na p\u0159edchoz\u00ED l\u00E9\u010Dbu v\u010Detn\u011B l\u00E9\u010Dby imatinibem a s Ph-pozitivn\u00ED akutn\u00ED lymfoblastickou leuk\u00E9mi\u00ED (Ph+ALL) rezistenc\u00ED \u010Di intoleranc\u00ED na p\u0159edchoz\u00ED l\u00E9\u010Dbu."@cs . "8" . . . . "415798" . "Dasatinib - nov\u00E1 mo\u017Enost c\u00EDlen\u00E9 l\u00E9\u010Dby nemocn\u00FDch s CML rezistentn\u00ED na imatinib"@cs . . "Dasatinib - nov\u00E1 mo\u017Enost c\u00EDlen\u00E9 l\u00E9\u010Dby nemocn\u00FDch s CML rezistentn\u00ED na imatinib"@en . "1"^^ . "3" . "S" . "15" . . "1214-8911" . "L\u00E9\u010Div\u00FD p\u0159\u00EDpravek Sprycel vyr\u00E1b\u00ED firma Bristol-Myers Squibb a je od listopadu 2006 v Evropsk\u00E9 unii a t\u00EDm i v \u010Cesk\u00E9 republice registrov\u00E1n k l\u00E9\u010Db\u011B dosp\u011Bl\u00FDch s chronickou myeloidn\u00ED leuk\u00E9mi\u00ED (CML) s rezistenc\u00ED \u010Di intoleranc\u00ED na p\u0159edchoz\u00ED l\u00E9\u010Dbu v\u010Detn\u011B l\u00E9\u010Dby imatinibem a s Ph-pozitivn\u00ED akutn\u00ED lymfoblastickou leuk\u00E9mi\u00ED (Ph+ALL) rezistenc\u00ED \u010Di intoleranc\u00ED na p\u0159edchoz\u00ED l\u00E9\u010Dbu." . "RIV/61989592:15110/07:00004035!RIV08-MSM-15110___" . "1"^^ . . . . "CZ - \u010Cesk\u00E1 republika" . . . "15"^^ . "Dasatinib - nov\u00E1 mo\u017Enost c\u00EDlen\u00E9 l\u00E9\u010Dby nemocn\u00FDch s CML rezistentn\u00ED na imatinib" . "15110" . "Faber, Edgar" . . "Medical Tribune" . "RIV/61989592:15110/07:00004035" . "CML; Bcr/Abl"@en . "Dasatinib - nov\u00E1 mo\u017Enost c\u00EDlen\u00E9 l\u00E9\u010Dby nemocn\u00FDch s CML rezistentn\u00ED na imatinib"@cs . . .